Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
Ji Hyun Yu, Kyoung Woon Kim, Bo-Mi Kim, Byung Ha Chung, Mi-La Cho, Bum Soon Choi, Cheol Whee Park, Yong-Soo Kim, Chul Woo Yang
Korean J Intern Med. 2016;31(3):552-559.   Published online 2016 Mar 11     DOI: https://doi.org/10.3904/kjim.2014.366
Citations to this article as recorded by Crossref logo
Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review
Susanne Wiegand, Gunnar Wichmann, Andreas Dietz
Lymphatic Research and Biology.2018; 16(4): 330.     CrossRef
Recuentos de células T reguladoras en sangre periférica como biomarcador predictivo del resultado del trasplante renal: revisión sistemática
Francisco Herrera-Gómez, Mónica Vásquez-Seoane, Waldo del Aguila, Débora Martín-García, Álvaro Maurtua-Briseño Meiggs, Anunciación González-López, Beatriz Andrés-Martín, Álvaro Nava-Rebollo, Fernando Casquero-Fernández, Pilar Pascual-Núñez, Jesús Grande-V
Medicina Clínica.2017; 149(12): 523.     CrossRef
Effect of sirolimus on arteriosclerosis induced by advanced glycation end products via inhibition of the ILK/mTOR pathway in kidney transplantation recipients
Zhen Xu, Xuzhong Liu, Zijie Wang, Jun Tao, Zhijian Han, Min Gu, Wei Zhang, Ruoyun Tan
European Journal of Pharmacology.2017; 813: 1.     CrossRef
Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review
Francisco Herrera-Gómez, Mónica Vásquez-Seoane, Waldo del Aguila, Débora Martín-García, Álvaro Maurtua-Briseño Meiggs, Anunciación González-López, Beatriz Andrés-Martín, Álvaro Nava-Rebollo, Fernando Casquero-Fernández, Pilar Pascual-Núñez, Jesús Grande-V
Medicina Clínica (English Edition).2017; 149(12): 523.     CrossRef